Indeed, leuprolide acetate, a GnRH agonist that lower serum levels of LH, has been shown to improve cognitive performance and decrease amyloid-β deposition in a mouse transgenic model of Alzheimer's disease [85]. The gene discussed is GNRH1; the disease is early-onset autosomal dominant Alzheimer disease.